source
- Patient death raises safety concerns before Bristol Myers lung drug readoutA patient died from a fatal liver injury while taking part in a trial of Bristol Myers Squibb's lung disease candidate. The company disclosed the incident in a May amendment to its trial documents…
- Bristol Myers revises Phase 3 fibrosis trial after liver safety events, including a deathBristol Myers Squibb announced a change to its late-stage Phase 3 "Aloft" trial of the experimental pulmonary fibrosis drug admilparant. The amendment adds closer monitoring for liver-related adve…